Largest evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated non-small cell lung cancer (NSCLC) and colorectal cancer (CRC): Plasma biomarker analysis of CodeBreaK100 Meeting Abstract
| Authors: | Li, B. T.; Velcheti, V.; Price, T. J.; Hong, D. S.; Fakih, M.; Kim, D. W.; Falchook, G. S.; Delord, J. P.; Dy, G. K.; Ramalingam, S. S.; Strickler, J. H.; Kurata, T.; Wolf, J.; Sacher, A. G.; Addeo, A.; Prenen, H.; Hindoyan, A.; Anderson, A.; Ang, A.; Skoulidis, F. |
| Abstract Title: | Largest evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated non-small cell lung cancer (NSCLC) and colorectal cancer (CRC): Plasma biomarker analysis of CodeBreaK100 |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300077 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.102 |
| Notes: | Meeting Abstract: 102 -- This meeting was also held virtually -- Source: Wos |
